CPIXNasdaqPharmaceutical PreparationsFiscal year ends December 31
CUMBERLAND PHARMACEUTICALS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$6.70−0.48 (-6.69%)
Close on Oct 19, 2026
- Market cap
- $100.38M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Cumberland Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Aug 28, 2026 | Aug 28, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 7, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 4, 2026 | Aug 4, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 13, 2026 | Jul 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 29, 2026 | Jul 1, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 24, 2026 | Jun 25, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 8, 2026 | SEC EDGAR |
| Current report | 8-K | May 5, 2026 | May 5, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 21, 2026 | Apr 24, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 22, 2026 | Apr 23, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2025 | Mar 9, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 9, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2026 | Mar 3, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 4, 2026 | Feb 4, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 18, 2025 | Nov 24, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 7, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2025 | Nov 4, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 21, 2025 | Oct 21, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 8, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2025 | Aug 5, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 9, 2025 | SEC EDGAR |
| Current report | 8-K | May 6, 2025 | May 6, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 28, 2025 | Apr 28, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 19, 2025 | Mar 19, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2024 | Mar 10, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 7, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 4, 2025 | Mar 4, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 19, 2025 | Feb 19, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 14, 2025 | Feb 14, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 4, 2025 | Feb 4, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 9, 2024 | Dec 9, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2024 | Nov 12, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 8, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2024 | Nov 6, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2024 | Nov 4, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 9, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2024 | Aug 6, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 10, 2024 | SEC EDGAR |
| Current report | 8-K | May 7, 2024 | May 7, 2024 | SEC EDGAR |